Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
MDGL
$427.39
+0.51%
MDGL
· Madrigal Pharmaceuticals, Inc.
$427.39
+2.18 (+0.51%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$9.93B
Shares
23.23M
Volume · Nov 13
441.32K
Avg daily vol (3M)
354.09K
All webcasts
Earnings call · FY2021 Q3
Madrigal Pharmaceuticals, Inc. (MDGL) Q3 2021 Earnings Call
Revenue
$0
Diluted EPS
-$3.79
Net income
-$63.10M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 4, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 4, 2021 · complete as-filed document